Emerging Infectious Disease ISSN: 1080-6059

Charbon pulmonaire d’origine bioterroriste: les 10 premiers cas rapportés aux Etats-Unis

John A. Jernigan*, David S. Stephens*†, David A. Ashford*, Carlos Omenaca‡, Martin S. Topiel§, Mark Galbraith¶, Michael Tapper#, Tamara L. Fisk*†, Sherif Zaki*, Tanja Popovic*, Richard F. Meyer*, Conrad P. Quinn*, Scott A. Harper*, Scott K. Fridkin*, James J. Sejvar*, Colin W. Shepard*, Michelle McConnell*, Jeannette Guarner*, Wun-Ju Shieh*, Jean M. Malecki**, Julie L. Gerberding*, James M. Hughes*, Bradley A. Perkins*, and members of the Anthrax Bioterrorism Investigation Team

Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA;; †Emory University School of Medicine, Atlanta, Georgia, USA;; ‡Cedars Medical Center, Miami, Florida, USA;; §Virtua Health, Mount Holly, New Jersey, USA;; ¶Winchester Medical Center, Winchester, Virginia, USA;; #Lenox Hill Hospital, New York City, New York, USA;; **Palm Beach County Department of Public Health, West Palm Beach, Florida, USA

Article in English

l'Article Principal

Tableau 2

Symptoms for 10 patients with bioterrorism-related inhalational anthrax, October - November 2001

Symptômes	n=10
Fièvre, frissons	10
Sueurs, souvent profuses	7
Fatigue, malaise, léthargie	10
Toux (légère ou improductive)	9
Nausées ou vomissements	9
Dyspnée	8
Gêne thoracique ou douleurs de type pleurétique	7
Myalgies	6
Maux de tête	5
Etat confusionnel	4
Douleurs abdominales	3
Maux de gorge	2
Rhinorrhée	1

l'Article Principal

¹Members of the team who contributed to the work presented in this manuscript are J. Aguilar, M. Andre, K. Baggett, B. Bell, D. Bell, M. Bowen, G. Carlone, M. Cetron, S. Chamany, B. De, C. Elie, M. Fischer, A. Hoffmaster, K. Glynn, R. Gorwitz, C. Greene, R. Hajjeh, T. Hilger, J. Kelly, R. Khabbaz, A. Khan, P. Kozarsky, M. Kuehnert, J. Lingappa, C. Marston, J. Nicholson, S. Ostroff, T. Parker, L. Petersen, R. Pinner, N. Rosenstein, A. Schuchat, V. Semenova, S. Steiner, F. Tenover, B. Tierney, T. Uyeki, S. Vong, D. Warnock, C. Spak, D. Jernigan, C. Friedman, M. Ripple, D. Patel, S. Pillai, S. Wiersma, R. Labinson, L. Kamal, E. Bresnitz, M. Layton, G. DiFerdinando, S. Kumar, P. Lurie, K. Nalluswami, L. Hathcock, L. Siegel, S. Adams, I. Walks, J. Davies-Coles, M. Richardson, K. Berry, E. Peterson, R. Stroube, H. Hochman, M. Pomeranz, A. Friedman-Kien, D. Frank, S. Bersoff-Matcha, J. Rosenthal, N. Fatteh, A. Gurtman, R. Brechner, C. Chiriboga, J. Eisold, G. Martin, K. Cahill, R. Fried, M. Grossman, and W. Borkowsky.

Haut de Page

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.